Cargando…
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
Type I and III interferons (IFN-I/λ) are important antiviral mediators against SARS-CoV-2 infection. Here, we demonstrate that plasmacytoid dendritic cells (pDC) are the predominant IFN-I/λ source following their sensing of SARS-CoV-2-infected cells. Mechanistically, this short-range sensing by pDCs...
Autores principales: | Venet, Manon, Ribeiro, Margarida Sa, Décembre, Elodie, Bellomo, Alicia, Joshi, Garima, Nuovo, Célia, Villard, Marine, Cluet, David, Perret, Magali, Pescamona, Rémi, Paidassi, Helena, Walzer, Thierry, Allatif, Omran, Belot, Alexandre, Trouillet-Assant, Sophie, Ricci, Emiliano P., Dreux, Marlène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907212/ https://www.ncbi.nlm.nih.gov/pubmed/36755036 http://dx.doi.org/10.1038/s41467-023-36140-9 |
Ejemplares similares
-
Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses
por: Webster, Brian, et al.
Publicado: (2018) -
Sensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation
por: Assil, Sonia, et al.
Publicado: (2019) -
Sensing of Immature Particles Produced by Dengue Virus Infected Cells Induces an Antiviral Response by Plasmacytoid Dendritic Cells
por: Décembre, Elodie, et al.
Publicado: (2014) -
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
por: Goncalves, David, et al.
Publicado: (2021) -
A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022
por: Guibert, Nicolas, et al.
Publicado: (2023)